How consistent are international treatment guidelines for bipolar disorder?

session-1989711_1280

Steven Marwaha publishes his debut blog on a review article that asks if there is consensus across international evidence-based guidelines for the management of bipolar disorder.

[read the full story...]

Antidepressants for bipolar depression: weighing up the benefits and harms

7347845622_508b764a51_k

Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.

[read the full story...]

Evidence-based guidelines for treating bipolar disorder

2704560472_63b23c8c4e_b

Joseph Hayes summarises the recent British Association for Psychopharmacology guidelines for the treatment of bipolar disorder, and compares their recommendations with those found in the NICE bipolar disorder guidance from 2014.

[read the full story...]

Is the NICE guideline for bipolar disorder biased in favour of psychosocial interventions?

3188732826_d2631dacc9_b

Guy Goodwin reviews a new paper in the Lancet Psychiatry by Jauhar, McKenna and Laws, that calls into question the trustworthiness of the NICE bipolar disorder guidance.

[read the full story...]

Lamotrigine, quetiapine and folic acid for bipolar depression: the CEQUEL trial

15802794635_256de371d5_k

Michael Ostacher considers the findings of the CEQUEL trial, which asks: Does lamotrigine treat bipolar depression when added to quetiapine, and does adding folic acid help any more?

[read the full story...]